Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research

Merkel cell carcinoma (MCC) is a rare neuroendocrine cutaneous cancer, with incidence of less than 1/100,000, low survival rates and variable response to chemotherapy or immunotherapy. Herein we explore the application of patient tumor organoids (PTOs) in modeling personalized research in this rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsythe, Steven D., Erali, Richard A., Laney, Preston, Sivakumar, Hemamylammal, Li, Wencheng, Skardal, Aleksander, Soker, Shay, Votanopoulos, Konstantinos I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380677/
https://www.ncbi.nlm.nih.gov/pubmed/35974123
http://dx.doi.org/10.1038/s41598-022-17921-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380677/
https://www.ncbi.nlm.nih.gov/pubmed/35974123
http://dx.doi.org/10.1038/s41598-022-17921-6

Ejemplares similares